VivoSeq
Infectious Disease

Measles Vaccine

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Measles Vaccine is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Unknown status1 · 14%
Terminated1 · 14%
Suspended1 · 14%

Clinical Trials

Trial Activity

7 trials

Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
Completed·—·Phase 2·NCT00891007·90 enrolled
Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT02325310·14 enrolled
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
Completed·SSerum Institute of India Pvt. Ltd.·Phase 1·NCT01557699·60 enrolled
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
Completed·BBandim Health Project·N/A·NCT02943681·3,812 enrolled
Measles Vaccine in HCW
Suspended·KKasr El Aini Hospital·Phase 3·NCT04357028·200 enrolled
Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants
Terminated·IInternational Vaccine Institute·Phase 2·NCT00624975·74 enrolled
Additional Measles Vaccine at 4 Months of Age
Unknown status·BBandim Health Project·Phase 4·NCT01486355

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)